Stryker Corporation provided earnings guidance for the full year 2024. For the period, Company expects organic net sales growth to be in the range of 8.5% to 9.5% with the pricing impact to be roughly flat. If foreign exchange rates hold near current levels, anticipate net sales will be moderately unfavorably impacted for the full year, being more negative in the first half of the year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
334.1 USD | +0.64% | +0.98% | +11.57% |
16/05 | Stryker Insider Sold Shares Worth $3,276,516, According to a Recent SEC Filing | MT |
16/05 | Everlasting momentum |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.57% | 127B | |
-5.24% | 11.32B | |
+3.22% | 9.04B | |
+38.90% | 5.56B | |
-21.83% | 4.72B | |
+8.74% | 3.45B | |
-6.82% | 2.86B | |
-13.32% | 2.04B | |
-6.99% | 2.07B | |
-23.90% | 1.77B |
- Stock Market
- Equities
- SYK Stock
- News Stryker Corporation
- Stryker Corporation Provides Earnings Guidance for the Full Year 2024